TCRT August 2004

category image Volume 3
No. 4 (p 309-410)
August 2004
ISSN 1533-0338

Fiducial Markers Implanted During Prostate Brachytherapy for Guiding Conformal External Beam Radiation Therapy (p 359-364)

Prostate movement imposes limits on safe dose-escalation with external beam radiation therapy. If the precise daily location of the prostate is known, dose escalation becomes more feasible. We have developed an approach to dose escalation using a combination of prostate brachytherapy followed by external beam radiation therapy in which fiducial markers are placed along with 125I seeds during transperineal interstitial permanent prostate brachytherapy. These markers serve to verify daily prostate location during the subsequent external beam radiotherapy. Prior to implementing this approach, preliminary studies were performed to test visibility of the markers. Three different 125I seed models, as well as gold and silver marker seeds were placed within tissue-equivalent phantoms. Images were obtained with conventional x-rays (75-85 kV) and 6 MV photons from a linear accelerator. All 125I seed models were clearly visible on conventional x-rays but none were seen with 6 MV photons. The gold markers were visible with both energies. The silver markers were visible with conventional x-rays and 6 MV x-rays, but not as clearly as the gold seeds at 6 MV. Subsequently, conventional x-rays, CT scans, and 6 MV port films were obtained in 29 patients in whom fiducial gold marker seeds were implanted into the prostate during 125I prostate brachytherapy. To address the possibility of ?seed migration? within the prostate, CT scans were repeated 5 weeks apart in 14 patients and relative positions of the gold seeds were evaluated. The repeated CT scans showed no change in intraprostatic gold marker location, suggesting minimal migration. The gold seeds were visible with conventional x-rays, CT, and 6 MV port films in all patients. During the course of external beam radiation therapy, the gold markers were visible on routine 6 MV port films and were seen in different locations from film to film suggesting prostate motion. Mean daily displacement was 4-5 mm in the anterior-posterior, and 4-5 mm in superior-inferior dimensions. Left-right displacement appeared less, averaging 2-3 mm.

We conclude that implantation of gold marker seeds during prostate brachytherapy represents an easily implemented and practical means of prostate localization during subsequent image-guided external beam radiotherapy. With such markers, conformality of the external beam component can be confidently improved without expensive new equipment.

Key words: Prostate cancer, Image-guided radiotherapy, Brachytherapy, Implanted markers.

James S. Welsh, M.S., M.D.1*
Christine Berta, M.S.3
Scott Borzillary, M.S.2
Celis Sam, N.P.2
Derek Shickell, M.S., M.D.4
Lisa Nobile, R.T.T.2
Marsha Greenberg, R.T.T.2
Stephanie Weiss, M.D.2
Nicholas Detorie, Ph.D.2

1University of Wisconsin-Madison
600 Highland Avenue
K4/B100 Clinical Sciences Center
Madison, WI 53792 USA
2Johns Hopkins Hospital
401 North Broadway
Baltimore, MD 21231 USA
3Virginia Commonwealth University
401 College Street
Richmond, VA 23298 USA
4Mayo Clinic
200 First Street
Rochester, MN 55905 USA
*welsh@humonc.wisc.edu


This work was presented in part at the 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2001, Chicago Ill.

Purchase Downloadable Full-text PDF of Articles

Corporate User

$100.00

University/Academic User

$50.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Member Login | Home | Editorial Board | Instructions | Subscribe | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.